Diabetes Analysis

Eli Lilly pipeline and deals: GLP-1, vaccines, and 2026 outlook

diabetes · 7 min

Novo Nordisk CagriSema Phase 3 Results: Obesity Catalyst Update

EMA · obesity · 7 min

Eli Lilly Retatrutide Phase 3: Safety Data and Competitive Implications

obesity · 5 min

Spotlight On: Four Things to Watch at ADA 2026

diabetes · 8 min

FDA Approves MannKind's Afrezza for Pediatric Diabetes Patients

FDA · diabetes · 7 min

Tracking Cellular Disruptions in Type 1 Diabetes: Insights for Pharma

diabetes · 3 min

COFEPRIS Drug Approvals 2026: What You Need to Know

COFEPRIS · 9 min

Inflation Reduction Act Drug Pricing: Impact on FDA Negotiations & Innovation 2026

FDA · Pharmaceutical Market · 9 min

SURPASS-CVOT Trial Results: Implications for Mounjaro's Cardiovascular Safety and FDA Labeling

FDA · Type 2 Diabetes · 6 min

COFEPRIS Drug Approvals 2026: Key Trends and Healthcare Implications

COFEPRIS · 10 min

Biosimilar Competition Impact: US Biologics Market Analysis 2026

FDA · Oncology · 13 min

AI in FDA Drug Approvals: What You Need to Know

FDA · Pharmaceutical development · 10 min